Option Care Health Maintains Market Perform Rating as Acquisition Deal Provides Clear Exit Catalyst

Citizens JMP reaffirmed a "market perform" rating on Option Care Health stock, which exceeded quarterly expectations with earnings of $0.45 per share versus $0.43 forecast and revenue of $1.44 billion up 1.9% year-over-year. The company has agreed to be acquired by CD&R and McKesson for $32.05 per share in cash, valuing the transaction at approximately $5.8 billion including debt. This acquisition agreement provides investors with a near-term valuation catalyst, with analyst consensus currently at "Hold" and an average price target of $29.70.

Option Care Health's recent financial performance demonstrates solid operational momentum ahead of its planned acquisition. The company's earnings beat and revenue growth signal effective execution despite modest year-over-year expansion. The $32.05 per-share cash offer from CD&R and McKesson represents a significant premium to analyst consensus expectations, reflecting buyer confidence in the business model. This transaction values the enterprise at $5.8 billion including existing debt obligations.

The acquisition agreement fundamentally reshapes the investment thesis for Option Care Health shareholders. Rather than evaluating long-term equity potential, investors now have a defined exit event with a clear price point and timeline. The gap between the acquisition price and current analyst price targets suggests the market may still be pricing in execution risk or timing uncertainty around deal completion.